- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
2287596925
- Umfang
-
X, 269 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
- Erschienen in
-
Progress in anti-cancer chemotherapy
- Ereignis
-
Veröffentlichung
- (wo)
-
Paris, Berlin, Heidelberg, New York, Barcelona, Hong Kong, Londres, Milan, Singapour, Tokyo
- (wer)
-
Springer
- (wann)
-
(2000)
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.03.2025, 11:59 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Springer
Entstanden
- (2000)
Ähnliche Objekte (12)
Progress in anti-cancer chemotherapy
Progress in chemotherapy, Vol. 3.. Anticancer section
Targeting CDK9 for anti-cancer therapeutics
Iridium compounds as prospective anti-cancer agents
Molecular aspects of anti-cancer drug action
Recent advances in chemotherapy, [...]. Anticancer section
Assessing the economic value of anti-cancer therapies
In-Silico Design of an Anti-Cancer Vaccine
Metal-peptide bioconjugates for targeted anti-cancer therapy
Machine learning-based anti-cancer drug treatment optimization
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing
Mesoporous metal phosphate-citrate nanoparticles as anti-cancer agents
Progress in anti-cancer chemotherapy
Progress in chemotherapy, Vol. 3.. Anticancer section
Targeting CDK9 for anti-cancer therapeutics
Iridium compounds as prospective anti-cancer agents
Molecular aspects of anti-cancer drug action
Recent advances in chemotherapy, [...]. Anticancer section
Assessing the economic value of anti-cancer therapies
In-Silico Design of an Anti-Cancer Vaccine
Metal-peptide bioconjugates for targeted anti-cancer therapy
Machine learning-based anti-cancer drug treatment optimization
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing
Mesoporous metal phosphate-citrate nanoparticles as anti-cancer agents
Progress in anti-cancer chemotherapy
Progress in chemotherapy, Vol. 3.. Anticancer section
Targeting CDK9 for anti-cancer therapeutics
Iridium compounds as prospective anti-cancer agents
Molecular aspects of anti-cancer drug action
Recent advances in chemotherapy, [...]. Anticancer section
Assessing the economic value of anti-cancer therapies
In-Silico Design of an Anti-Cancer Vaccine
Metal-peptide bioconjugates for targeted anti-cancer therapy
Machine learning-based anti-cancer drug treatment optimization
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing